- Home
- Companies
- canada new brunswick
- clinical development
Refine by
Industries served
- Medical / Health Care
- Chemical & Pharmaceuticals
- Monitoring and Testing
- Environmental
- Manufacturing, Other
- Agriculture
- Health and Safety
- Banking & Finance / Insurance / Legal
- Defense
- Aerospace & Air Transport
- Retail
- Waste and Recycling
- Air and Climate
- Soil and Groundwater
- University / Academia / Research
- Food and Beverage
- Energy
- Construction & Construction Materials
Clinical Development Suppliers Serving New Brunswick
303 companies found
based inBuffalo, NEW YORK (USA)
KSL Biomedical companies specialize in translational medicine impacting immunology, Oncology and Genomics. KSL can provide a full suite of regulatory, quality, clinical consulting and contract research organization ...
KSL has professionals with many decades of experience in US and international regulatory compliance, product design and development, clinical trials, and protection of intellectual property to work with health care ...
based inTacoma, WASHINGTON (USA)
Since 1965, AST has been delivering innovative solutions – many of which were industry firsts and have since become industry standards. AST has always understood that our customers serve demanding and oftentimes unpredictable markets. We also ...
based inStockholm, SWEDEN
Recipharm develops and manufactures inhalation products and devices including integrated drug solutions, medical check valves and injection devices. Whether you’re a big pharma company outsourcing a key stage of your production or a small to medium ...
Recipharm offers a range of inhalation manufacturing and development capabilities for novel respiratory products. Our modern, well equipped facility in Holmes Chapel offers manufacturing, packaging and warehousing facilities for ...
based inBerlin, GERMANY
MerLion Pharmaceuticals is a biopharma company focusing on the research and development of drugs for the treatment of serious bacterial infections. MerLion - located in Berlin-Buch, Germany - manages the non-clinical and clinical development as well ...
based inVancouver, BRITISH COLUMBIA (CANADA)
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet ...
based inNiel, BELGIUM
eTheRNA has developed a proprietary and integrated set of platform technologies that are overcoming the challenges facing the development of next generation mRNA therapeutics. Our platform includes mRNA construct design and optimization, proprietary ...
Our mRNA platforms and vast in-house experience help partners quickly optimize, screen and select an mRNA code, develop a candidate, and ensure effective & prime manufacturing of the mRNA from research grade to GMP scale. Our platform’s ...
based inSomerset, NEW JERSEY (USA)
As the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world, we conduct all our business responsibly and with integrity. Our ...
The biologics market is experiencing high growth. However, the path to clinic for biologics is complex, requiring a substantial amount of time and resources to ensure success. Sponsor companies are looking for an “all of the ...
based inPearl River, NEW YORK (USA)
Auro Vaccines LLC is a clinical-stage vaccine development company pioneering a major evolutionary step in the design and development of preventive and therapeutic vaccines for infectious diseases. Our novel approach is based on a proprietary ...
Auro Vaccines has developed VesiculoVax™-vectored vaccines for pre- and post-exposure protection against the hemorrhagic disease caused by multiple species of filovirus (i.e. Zaire ebolavirus, Sudan ebolavirus and Marburg ...
based inFlintshire, UNITED KINGDOM
Quay Pharma is an independent, privately owned contract development manufacturing organisation (CDMO). Since 2002 we have proudly delivered over 250 successful projects and exercised continued improvement whilst remaining true to our core values. ...
We are extensively involved in developing early clinical formulations and clinical manufacturing of First in Human trials. We can develop a formulation specifically designed to ...
based inMontreal, QUEBEC (CANADA)
As a specialty therapeutics, clinical-stage biotech company, Inversago Pharma develops new generations of peripherally-acting cannabinoid-1 receptor (CB1) inverse agonists for the treatment of diabetic kidney disease, type 1 and type 2 diabetes, ...
based inCarlsbad, CALIFORNIA (USA)
Since 1985, B&B Medical Technologies has developed clinically proven endotracheal tube holders, tracheostomy anti- disconnect devices and nebulizers for adult and pediatric patients, and bubble CPAP valves. B&B products offer versatile applications ...
based inEGYPT
UltraCare Co., Ltd., established in 2016, is a dedicated enterprise focused on research and manufacturing of clinical in vitro diagnostic (IVD) products. The company offers a comprehensive portfolio covering key platforms such as biochemistry, ...
based inSan Lazzaro di Savena (BO), ITALY
At Angiodroid we are committed to create new solutions for healthcare through combining our clinical and engineering expertise with human insights to develop innovations that can improve the quality of people’s lives. Our patented and CE marked ...
based inWixom, MICHIGAN (USA)
DiaSys Diagnostic Systems emerged as pioneer in the field of liquid stable reagents and has developed to an established provider of diagnostic solutions for the clinical laboratory. DiaSys develops, manufactures and markets diagnostic systems of ...
based inMorton Grove, ILLINOIS (USA)
Regis Technologies, Inc. partners with pharmaceutical and biotechnology companies to help expedite their drug candidates to market. Regis has the technical and operational capabilities to fully support our clients' preclinical and clinical API ...
based inSan Diego, CALIFORNIA (USA)
Vala Sciences helps researchers achieve an unrivaled in vitro understanding of how human cells respond to drug compounds. Vala is committed to providing expert services to pharmaceutical developers and researchers to help overcome the persistent ...
ValaDATE (Deep Analytics for Toxicity & Efficacy) AI is Vala’s development stage artificial intelligence platform that we believe will further automate and accelerate how we process the vast data produced by the Vala ...
based inShanghai, CHINA
Shanghai Kinetic Medical Limited Co., Ltd. is mainly engaged in the export trade of high-end medical instrument in China . Our factory is a high-end medical instrument group integrating R&D, production and sales of medical devices in China, which ...
based inNeedham, MASSACHUSETTS (USA)
Invicro is an integral part of the REALM IDx, Inc. group, which aims to accelerate personalized medicine, discover novel therapeutic targets and develop innovative therapeutic technologies for unmet medical needs. As a global research partner to the ...
Radiopharmaceutical therapies represent an effective way to treat solid cancers by using tumor targeting small molecules, peptides or biologics to deliver a cytotoxic payload that induces DNA damage in tumor cells, while limiting damage to normal ...
based inOslo, NORWAY
Bio-Me is Setting the Standard for Routine Microbiome Analysis. Gut microbiome research has become essential to almost every medical research field. Next-generation sequencing (NGS) technologies have been crucial in enabling a breakthrough in our ...
PMP™ technology – Bridging the gap between clinical research and clinical practice by translating knowledge into actionable information. Microbiome Analysis Services for Pharma and Drug ...
based inCranbury, NEW JERSEY (USA)
Advancing an integrated pipeline of genetic therapies that correct the root cause of complex and rare life-threatening childhood disorders. Our mission is to develop first-in-class and best-in-class, curative gene therapies for patients with ...
Rocket’s Research and Discovery group in the Cranbury, New Jersey facility utilizes approximately 20,000 square feet of state-of-the-art laboratories for designing, optimizing and advancing candidate therapeutics to clinical ...
